Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
JAMA Neurology
Published October 5, 2026
Earlier Disclosure of Blood-Based Biomarkers, Diagnostic Certainty, and Clinical Management: A Ra...
October 6, 2026
Medspoke
Medspoke
Neurology
Published October 5, 2026
00:00
--:--
Ofatumumab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Nationwide Cohort Study.
October 6, 2026
Share
Ofatumumab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Nationwide Cohort Study.
https://www.medspoke.co/channel_journal?id=792&tap_id=15115
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
World Journal of Urology
Published October 5, 2026
The effect of ureteral stenting on the risk of metachronous upper tract urothelial carcinoma in p...
October 6, 2026
Why are you reporting this TALK?